Administration of Psychotropic Medication to Unaccompanied Alien Children

Forms and Documents

Forms and supporting documents for this ICR

Document	Type	Status	Availability
Form MMH-2 (Spanish) Psychotropic Medication Assent Notice - Spanish	Form and Instruction	Modified	Available
Form MMH-2 Psychotropic Medication Assent Notice	Form and Instruction	Modified	Available
Form MMH-1 (Spanish) Psychotropic Medication Informed Consent - Spanish	Form and Instruction	Modified	Available
Form MMH-1 Psychotropic Medication Informed Consent	Form and Instruction	Modified	Available
Nonsub Memo_0970-0641_Psych Meds_003_2026 03 19.docx	Justification for No Material/Nonsubstantive Change	Uploaded 2026-03-19	Available
SSA Attachment A_0970-NEW_Psych Meds_001_2024 11 12.docx	Supplementary Document	Uploaded 2024-11-12	Available
SSA_0970-0641_Psych Meds_002_2026 03 19 CLEAN.docx	Supporting Statement A	Uploaded 2026-03-19	Available

IC Document Collections

Information collection document groups

IC ID	Collection	Type	Status	Form
272297	Psychotropic Medication Assent Notice (Form MMH-2)	Form and Instruction	Modified	Psychotropic Medication Assent Notice - Spanish
272297	Psychotropic Medication Assent Notice (Form MMH-2)	Form and Instruction	Modified	Psychotropic Medication Assent Notice
272297	Psychotropic Medication Assent Notice (Form MMH-2)	Form and Instruction	Modified
272295	Psychotropic Medication Informed Consent (Form MMH-1)	Form and Instruction	Modified	Psychotropic Medication Informed Consent - Spanish
272295	Psychotropic Medication Informed Consent (Form MMH-1)	Form and Instruction	Modified	Psychotropic Medication Informed Consent
272295	Psychotropic Medication Informed Consent (Form MMH-1)	Form and Instruction	Modified

ICR Details

OMB Control No: 0970-0641	ICR Reference No: 202603-0970-009
Status: Active	Previous ICR Reference No: 202411-0970-005
Agency/Subagency: HHS/ACF	Agency Tracking No: ORR - UCB
Title: Administration of Psychotropic Medication to Unaccompanied Alien Children
Type of Information Collection: No material or nonsubstantive change to a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 03/23/2026
Retrieve Notice of Action (NOA)	Date Received in OIRA: 03/20/2026
Terms of Clearance:

table that charts list comparision

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	01/31/2028	01/31/2028	01/31/2028
Responses	900	0	900
Time Burden (Hours)	1,125	0	1,125
Cost Burden (Dollars)	0	0	0

---

Abstract: The Administration of Psychotropic Medication to Unaccompanied Children information collection contains two (2) instruments that allow the Office of Refugee Resettlement (ORR) to obtain informed consent from authorized consenters and informed assent or agreement from unaccompanied children for the administration of psychotropic medication. The collection was last approved by OMB on January 10, 2025 and the current expiration date is January 31, 2028. ORR proposes revisions for both forms in this collection: Psychotropic Medication Informed Consent (Form MMH-1) Psychotropic Medication Assent Notice (Form MMH-2) ORR proposes the following: - Changing the information collection title to Administration of Psychotropic Medication to Unaccompanied Alien Children. - Revisions to bring both forms into compliance with Executive Order 14168, Defending Women from Gender Ideology Extremism and Restoring Biological Truth to the Federal Government. - Updating references to its Division of Health in Form MMH-1 to reflect a recent organizational realignment that changed the division’s name (update to Division of Health, DoH). - To assist care providers in complying with the regulatory requirements found in 45 CFR 410.1306 Language Access Services, ORR proposes translating the forms into Spanish.

---

Authorizing Statute(s): US Code: 6 USC 279 Name of Law: Homeland Security Act (HSA)
   US Code: 8 USC 1232 Name of Law: William Wilberforce Trafficking Victims Protection Reauthorization Act of 2008 (TVPRA)
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	89 FR 59115	07/22/2024
30-day Notice:	Federal Register Citation:	Citation Date:
	89 FR 90295	11/15/2024
Did the Agency receive public comments on this ICR? Yes

---

Number of Information Collection (IC) in this ICR: 2

table that charts list of burden

IC Title	Form No.	Form Name
Psychotropic Medication Assent Notice (Form MMH-2)	MMH-2, MMH-2 (Spanish)	Psychotropic Medication Assent Notice ,   Psychotropic Medication Assent Notice - Spanish
Psychotropic Medication Informed Consent (Form MMH-1)	MMH-1 , MMH-1 (Spanish)	Psychotropic Medication Informed Consent ,   Psychotropic Medication Informed Consent - Spanish

---

ICR Summary of Burden

table that charts list of burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	900	900	0	0	0	0
Annual Time Burden (Hours)	1,125	1,125	0	0	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement:

---

Annual Cost to Federal Government: $20,181

Does this IC contain surveys, censuses, or employ statistical methods? No

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination.     Yes

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination.     Yes

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? No

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 03/20/2026

---